Furthermore, in a mouse xenograft model, cotreatment with naringenin and TRAIL markedly suppressed U251-MG-derived glioma growth by activating apoptosis in tumor tissues, compared to naringenin or TRAIL monotherapy [80]. This evidence concerns the gene TNFSF10 and central nervous system cancer.